Overall rank by patents
#26,529
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 12 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06V (IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING).
The verdict
Inhandplus holds 10 US patents across 12 technology areas, rank #26,529 of 50,000 tracked assignees.
Inhandplus Inc. has been granted 10 US utility patents between 2022 and 2025, placing Inhandplus Inc. at rank #26,529 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.7 claims per patent with primary concentration in G06V (IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING). As a Foreign Corporation, Inhandplus Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Inhandplus sits between Infinity Drain Ltd. (10 patents, rank #26,525) and INO Therapeutics Llc (10 patents, rank #26,533) - the closest US assignees by grant volume. The composite Innovation Score of 48.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Inhandplus Inc.'s 12.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Inhandplus Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
INFINITY DRAIN LTD.
10 patents
INFOSEC GLOBAL INC.
10 patents
INFOVISTA SAS
10 patents
INGENIOUS DESIGNS LLC
10 patents
INJECTIMED, INC.
10 patents
INNOVASIC, INC.
10 patents
INNOVHEART S.r.l.
10 patents
INO Therapeutics LLC
10 patents
INHANDPLUS INC.
10 patents
What this shows Inhandplus holds 10 patents at rank #26,529, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Inhandplus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 30.0% |
| 2023 | 4 | 40.0% |
| 2024 | 1 | 10.0% |
| 2025 | 2 | 20.0% |
Top 12 of 12 technology areas
Overall rank by patents
#26,529
Across all tracked assignees
48.1 out of 100
How to use this portfolio
Inhandplus's 10 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.